[go: up one dir, main page]

CY1119390T1 - Παιδιατρικο διαλυμα που περιλαμβανει προπρανολολη - Google Patents

Παιδιατρικο διαλυμα που περιλαμβανει προπρανολολη

Info

Publication number
CY1119390T1
CY1119390T1 CY20171100562T CY171100562T CY1119390T1 CY 1119390 T1 CY1119390 T1 CY 1119390T1 CY 20171100562 T CY20171100562 T CY 20171100562T CY 171100562 T CY171100562 T CY 171100562T CY 1119390 T1 CY1119390 T1 CY 1119390T1
Authority
CY
Cyprus
Prior art keywords
propanolol
solution including
pediatric
pediatric solution
present
Prior art date
Application number
CY20171100562T
Other languages
English (en)
Inventor
Christine Chaumont
Jean-François Cordoliani
Elie Leverd
Valérie Muguet
Original Assignee
Pierre Fabre Dermatologie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40940328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1119390(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pierre Fabre Dermatologie filed Critical Pierre Fabre Dermatologie
Publication of CY1119390T1 publication Critical patent/CY1119390T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seasonings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε υδατικά μη αλκοολούχα διαλύματα που περιλαμβάνουν ένα βήτα-αναστολέα, ένα μη σακχαρώδους τύπου γλυκαντικό και τα οποία είναι ουσιαστικά χωρίς αρωματικό συντηρητικό. Τα διαλύματα της παρούσας εφεύρεσης είναι συγκεκριμένα προσαρμοσμένα για παιδιατρική χρήση.
CY20171100562T 2009-04-21 2017-05-31 Παιδιατρικο διαλυμα που περιλαμβανει προπρανολολη CY1119390T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09290298A EP2246044A1 (en) 2009-04-21 2009-04-21 Paediatric solutions comprising a beta-blocker
EP10717263.7A EP2421504B2 (en) 2009-04-21 2010-04-12 Paediatric solutions comprising propranolol
PCT/IB2010/051573 WO2010122442A1 (en) 2009-04-21 2010-04-12 Paediatric solutions comprising a beta-blocker

Publications (1)

Publication Number Publication Date
CY1119390T1 true CY1119390T1 (el) 2018-02-14

Family

ID=40940328

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20171100562T CY1119390T1 (el) 2009-04-21 2017-05-31 Παιδιατρικο διαλυμα που περιλαμβανει προπρανολολη
CY181100939T CY1120667T1 (el) 2009-04-21 2018-09-07 Παιδιατρικα διαλυματα που περιλαμβανουν ενα βητα-αναστολεα

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY181100939T CY1120667T1 (el) 2009-04-21 2018-09-07 Παιδιατρικα διαλυματα που περιλαμβανουν ενα βητα-αναστολεα

Country Status (32)

Country Link
US (2) US20120035270A1 (el)
EP (4) EP2246044A1 (el)
JP (1) JP5695029B2 (el)
KR (1) KR101713866B1 (el)
CN (1) CN102405041A (el)
AR (2) AR076338A1 (el)
AU (1) AU2010240551B2 (el)
BR (1) BRPI1015447B1 (el)
CA (1) CA2755175C (el)
CL (1) CL2011002634A1 (el)
CO (1) CO6410278A2 (el)
CY (2) CY1119390T1 (el)
DK (2) DK2497461T4 (el)
ES (2) ES2623936T5 (el)
GE (1) GEP20146087B (el)
HR (2) HRP20170610T4 (el)
HU (2) HUE034581T2 (el)
IL (1) IL214674A (el)
LT (2) LT2421504T (el)
MA (1) MA33003B1 (el)
MX (1) MX337463B (el)
NZ (1) NZ594592A (el)
PL (2) PL2421504T5 (el)
PT (2) PT2497461T (el)
RS (2) RS55862B2 (el)
RU (1) RU2011139233A (el)
SG (1) SG172960A1 (el)
SI (2) SI2497461T2 (el)
TN (1) TN2011000350A1 (el)
TW (1) TWI429459B (el)
UA (1) UA107570C2 (el)
WO (1) WO2010122442A1 (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246044A1 (en) 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker
KR102051800B1 (ko) 2011-03-04 2019-12-04 그뤼넨탈 게엠베하 경구 투여를 위한 타펜타돌의 수성 약제학적 제형
KR101970468B1 (ko) * 2011-03-04 2019-04-19 그뤼넨탈 게엠베하 타펜타돌의 비경구 투여
JP2019142972A (ja) * 2011-03-04 2019-08-29 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口的投与
US9724297B2 (en) 2014-04-01 2017-08-08 Arbor Pharmaceuticals, Inc. Sotalol compositions and uses of the same
PT3273953T (pt) 2015-03-27 2019-04-01 Gruenenthal Gmbh Formulação estável para administração parentérica de tapentadol
BR112019005439A2 (pt) 2016-09-23 2019-06-18 Gruenenthal Gmbh formulação estável para administração parenteral de tapentadol
CN108261411B (zh) * 2016-12-30 2021-04-30 武汉科福新药有限责任公司 用于婴幼儿血管瘤治疗的口腔膜剂及其制备方法
CN107320467A (zh) * 2017-07-21 2017-11-07 江苏云阳集团药业有限公司 一种盐酸普萘洛尔药用组合物及其制备方法
CN108299279B (zh) * 2018-02-09 2021-03-23 北京梅尔森医药技术开发有限公司 取代芳基胺醇化合物及其制备方法和用途
US11547123B2 (en) * 2019-08-16 2023-01-10 The Folger Coffee Company Methods for reducing negative flavor attributes in coffee and compositions therefrom
JPWO2022071481A1 (el) 2020-09-30 2022-04-07
CN116407495A (zh) * 2023-03-09 2023-07-11 北京梅尔森医药技术开发有限公司 一种阿替洛尔口服溶液及其制备方法和应用
GB2628566A (en) 2023-03-29 2024-10-02 Novumgen Ltd An orally rapidly disintegrating tablet of propranolol and its process of preparation
WO2025068937A1 (en) 2023-09-30 2025-04-03 Liqmeds Worldwide Limited An oral liquid formulation of metoprolol
CN118021718B (zh) * 2024-04-12 2024-07-02 成都瑞尔医药科技有限公司 一种盐酸普罗帕酮注射液及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600708A (en) 1985-07-19 1986-07-15 American Home Products Corporation Propranolol hydrochloride liquid formulations
HU209251B (en) 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
EP0732064B1 (en) 1995-03-15 2001-06-06 Kao Corporation Use of a bitterness relieving agent
JPH1025253A (ja) * 1996-07-12 1998-01-27 Kao Corp 苦味低減化剤及び苦味低減化法
JPH11349492A (ja) * 1998-06-03 1999-12-21 Yamanouchi Pharmaceut Co Ltd 苦味を低減した経口用医薬組成物および苦味低減化方法
JP2001342151A (ja) * 2000-03-31 2001-12-11 Eisai Co Ltd 甘味を有する薬剤組成物
MXPA03009392A (es) * 2001-05-25 2004-01-29 Warner Lambert Co Composicion famaceutica liquida.
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
EP1850854A1 (en) * 2005-02-25 2007-11-07 Biomarin Pharmaceutical Inc. Room temperature stable aqueous liquid pharmaceutical composition
US20060270611A1 (en) * 2005-05-25 2006-11-30 Dries Willy M A Pediatric formulation of topiramate
DE102006020604A1 (de) * 2006-05-02 2007-11-08 Bayer Healthcare Ag Flüssige Arzneimittelformulierung
EP2050441A1 (en) 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
WO2009129592A1 (en) * 2008-04-25 2009-10-29 Apotex Technologies Inc. Liquid formulation for deferiprone with palatable taste
EP2246044A1 (en) 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker

Also Published As

Publication number Publication date
EP2497461B2 (en) 2021-12-15
MX2011010766A (es) 2011-10-21
RS55862B2 (sr) 2022-12-30
PT2421504T (pt) 2017-06-16
CL2011002634A1 (es) 2012-06-08
IL214674A0 (en) 2011-09-27
SI2497461T1 (sl) 2018-10-30
LT2421504T (lt) 2017-06-12
EP2497461A2 (en) 2012-09-12
ES2685178T3 (es) 2018-10-05
KR101713866B1 (ko) 2017-03-09
EP3384899A1 (en) 2018-10-10
SG172960A1 (en) 2011-08-29
EP2497461A3 (en) 2014-01-01
TW201039862A (en) 2010-11-16
ES2623936T5 (es) 2022-11-28
JP5695029B2 (ja) 2015-04-01
EP2497461B1 (en) 2018-06-20
SI2497461T2 (sl) 2022-04-29
EP2421504B1 (en) 2017-03-08
BRPI1015447A2 (pt) 2016-04-19
HUE039937T2 (hu) 2019-02-28
LT2497461T (lt) 2018-10-10
TN2011000350A1 (en) 2013-03-27
GEP20146087B (en) 2014-05-13
PL2497461T3 (pl) 2018-12-31
DK2421504T3 (en) 2017-05-01
WO2010122442A1 (en) 2010-10-28
NZ594592A (en) 2013-11-29
EP2421504B2 (en) 2022-08-10
BRPI1015447B1 (pt) 2020-01-28
TWI429459B (zh) 2014-03-11
HUE034581T2 (en) 2018-02-28
HRP20181408T1 (hr) 2018-11-02
AR117621A2 (es) 2021-08-18
BRPI1015447A8 (pt) 2017-10-03
HRP20181408T4 (hr) 2022-03-04
US20120035270A1 (en) 2012-02-09
DK2497461T4 (da) 2022-02-14
CA2755175A1 (en) 2010-10-28
AU2010240551B2 (en) 2015-07-16
PT2497461T (pt) 2018-10-23
UA107570C2 (xx) 2015-01-26
RS55862B1 (sr) 2017-08-31
CY1120667T1 (el) 2019-12-11
PL2497461T5 (pl) 2022-06-27
AU2010240551A1 (en) 2011-08-04
KR20120015305A (ko) 2012-02-21
PL2421504T5 (pl) 2023-01-02
EP2421504A1 (en) 2012-02-29
RS57668B2 (sr) 2022-03-31
DK2421504T4 (da) 2022-11-14
DK2497461T3 (en) 2018-09-03
IL214674A (en) 2017-01-31
US20150087719A1 (en) 2015-03-26
PL2421504T3 (pl) 2017-08-31
RS57668B1 (sr) 2018-11-30
CN102405041A (zh) 2012-04-04
ES2685178T5 (es) 2022-04-13
MX337463B (es) 2016-03-07
AR076338A1 (es) 2011-06-01
CA2755175C (en) 2018-01-02
MA33003B1 (fr) 2012-01-02
RU2011139233A (ru) 2013-05-27
JP2012524773A (ja) 2012-10-18
CO6410278A2 (es) 2012-03-30
HRP20170610T1 (hr) 2017-07-28
EP2246044A1 (en) 2010-11-03
ES2623936T3 (es) 2017-07-12
HRP20170610T4 (hr) 2022-12-09
SI2421504T1 (sl) 2017-06-30

Similar Documents

Publication Publication Date Title
CY1119390T1 (el) Παιδιατρικο διαλυμα που περιλαμβανει προπρανολολη
BRPI0923409A2 (pt) cabeça de escova de dentes, e, escova de dentes.
SI2324831T1 (sl) Terapija s pirfenidonom, izogibajoäśa se fluvoksaminu
HRP20140327T4 (hr) Lentiviralni vektori pseudotipizirani sa glikoproteinom ovojnice virusa sindbis
NO2021006I1 (no) Quofenix, delafloksacin
BRPI1012313A2 (pt) derivados de isoindolina-1,3-diona substituida
BRPI0911767A2 (pt) Processo, e, composto.
BR112013016212A2 (pt) composição aquosa de cuidado oral compreendendo goma xantana, goma de celulose e carbômero.
BRPI1012929A2 (pt) válvula, e, mecanismo de acionamento melhorado.
BRPI0917321A2 (pt) prevenção, tratamento e diagnóstico de infecção por p. gingivalis
BRPI1008955A2 (pt) Terapia de combinação com derivados de tiocolchicina.
DK2427436T3 (da) Substituerede aromatiske carboxamid og urea derivater som vanilloidreceptorligander.
LT2451482T (lt) Kombinuota terapija, skirta diabeto gydymui
BRPI0809672A2 (pt) Solução de peróxido de hidrogênio aquosa, processo para a preparação da solução de peróxido de hidrogênio aquosa, uso da solução de peróxido de hidrogênio aquosa, e, processo para a fabricação de óxido de propileno ou epicloroidrina.
BRPI1016117A2 (pt) derivados de isoxazol-isoxazol e isoxasol-isotiazol.
BRPI1014691A2 (pt) Composto, e, processo para a preparação de um composto.
BRPI0924081A2 (pt) DERIVADOS DE 5- AMINO -2-(1-hIDROXI-ETIL)- TETRAHIDROPIRANO.
BRPI1010021A2 (pt) mandril, e, combinação do mandril
BRPI1016039A2 (pt) processo, e, composição antimascaramento.
BR112012000423A2 (pt) catalizador enzimático heterogêneo, processo de preparação, e, utilização do mesmo.
SI2630174T1 (sl) Vodni pripravki, ki imajo lastnosti mehkega otipa
CY1114488T1 (el) Διεργασιες και ενδιαμεσα για την παρασκευη ενος μακροκυκλικου αναστολεα πρωτεασης του hcv
BRPI0918036A2 (pt) cortador lateral.
BRPI1011622A2 (pt) conjunto oscilador, método de perfuração, e, cabeça de perfuração.
BRPI1014904A2 (pt) derivados de quinazolinadiona, preparação dos mesmos e vários usos terapêuticos dos mesmos.